Selection of Rilpivirine-Resistant HIV-1 in a Seroconverter...

  • Main
  • 2015 / 11
  • Selection of Rilpivirine-Resistant HIV-1 in a Seroconverter...

Selection of Rilpivirine-Resistant HIV-1 in a Seroconverter From the SSAT 040 Trial Who Received the 300-mg Dose of Long-Acting Rilpivirine (TMC278LA)

Penrose, Kerri J., Parikh, Urvi M., Hamanishi, Kristen A., Else, Laura, Back, David, Boffito, Marta, Jackson, Akil, Mellors, John W.
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Language:
english
Journal:
Journal of Infectious Diseases
DOI:
10.1093/infdis/jiv528
Date:
November, 2015
File:
PDF, 868 KB
english, 2015
Conversion to is in progress
Conversion to is failed